Reyon Pharmaceutical Co Ltd
KRX:102460
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Reyon Pharmaceutical Co Ltd
KRX:102460
|
KR |
|
Carlyle Commodities Corp
F:BJ4
|
CA |
|
I
|
Instant Group AG
XMUN:CCB
|
DE |
|
K
|
Kulmbacher Brauerei Aktien-Gesellschaft
XMUN:KUL
|
DE |
|
K&S AG
F:SDF
|
DE |
|
H
|
Hanchem Co Ltd
KOSDAQ:457370
|
KR |
|
Eco Oro Minerals Corp
F:GQQ
|
CA |
|
T
|
Toyam Industries Ltd
BSE:538607
|
IN |
|
Mercurity Fintech Holding Inc
NASDAQ:CD
|
US |
|
Millennial Potash Corp
XTSX:MLP
|
CA |
|
W
|
Wellspire Holdings Bhd
KLSE:WELLS
|
MY |
|
Kurganskaya Generiruyushchaya Kompaniya PAO
MOEX:KGKC
|
RU |
Dividends
Dividend Yield
Reyon Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Reyon Pharmaceutical Co Ltd
Payout Ratio
Reyon Pharmaceutical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Reyon Pharmaceutical Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Reyon Pharmaceutical Co Ltd
| Average Annual Return | -31.87% |
| Standard Deviation of Annual Returns | 10.13% |
| Max Drawdown | -84% |
| Market Capitalization | 185.4B KRW |
| Shares Outstanding | 18 590 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Reyon Pharmaceutical Co Ltd's latest stock split occurred on Dec 29, 2020
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, Reyon Pharmaceutical Co Ltd traded at 20849.9962 per share. Afterward, the share price was about 20757.4782.
The adjusted shares began trading on Dec 29, 2020. This was stock split number 2 in Reyon Pharmaceutical Co Ltd's history, following the previous one in Nov 29, 2017.
